MKI67 and diffuse large B-cell lymphoma: DE-DLBCL patients with Ki67 index >75% treated with ZR-CHOP had significantly longer PFS than those treated with R-CHOP (1-year PFS rate: 92.9% vs. 67.5%, P= 0.034).